F.D.A. advisers voted that the benefits of a nonprescription pill outweigh the risks. If the agency decides to move on the recommendation, the progestin-only contraceptive could be in stores within a few months.
Share this post
F.D.A. advisers voted that the benefits of a nonprescription pill outweigh the risks. If the agency decides to move on the recommendation, the progestin-only contraceptive could be in stores within a few months.